WHO ICTRP trial
The effect of dexmedetomidine on reducing the incidence of cough after…
IRCT20180416039326N19 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20180416039326N19 |
|---|---|
| Public title | The effect of dexmedetomidine on reducing the incidence of cough after extubation |
| Scientific title | Comparison of safety and efficacy of two doses of Dexmedetomidine in reducing the incidence of cough after endotracheal tube removal in a patient undergoing elective surgery |
| Primary sponsor | Esfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Tracheal Extubation. |
| Interventions | Intervention 1: Intervention group 1: In this group, the syringe containing dexmedetomidine (from Behestan Daroo company) is diluted to 1mcg / kg in 100 ml of normal saline and infused into the patient within ten minutes. Intervention 2… |
| Registration date | Sep 16, 2021 |
| Target size | 540 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: